Autism behavior drug shows promise in kids

NCT ID NCT00332241

Completed Symptom relief Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. Source: ClinicalTrials.gov ↗

First seen May 14, 2026 · Last updated May 22, 2026 · Updated 2 times

Summary

This study tested whether aripiprazole, a medication, could reduce serious behavioral issues like irritability and agitation in children and teens (ages 6-17) with autism. Participants received either the drug or a placebo for 8 weeks. The goal was to see if the drug improved behavior more than a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISTIC DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Center For Psychiatry And Behavioral Medicine

Las Vegas, Nevada, 89128, United States
Child Neurology Associates, Pc

Atlanta, Georgia, 30342, United States
Marsella, Gregory

Boca Raton, Florida, 33432, United States
Neurobehavioral Medicine Group

Bloomfield Hills, Michigan, 48302, United States
Red Oak Psychiatry Associates, Pa

Houston, Texas, 77090, United States
Suny - Stony Brook School Of Medicine

Stony Brook, New York, 11794, United States
Univ Of Nc

Chapel Hill, North Carolina, 27599, United States
University Of Louisville

Louisville, Kentucky, 40202, United States
Ut Medical Group

Memphis, Tennessee, 38105, United States

Conditions

Explore the condition pages connected to this study.

AUTISTIC DISORDER